Related Experiment Video
Updated: May 20, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Designing an interoperable solution to support pharmacogenomic-guided prescribing in primary care: an implementer
Videha Sharma1, John McDermott2,3, Jessica Keen3
1Centre for Health Informatics, Division of Informatics, Imaging and Data Science, The University of Manchester, Manchester, UK videha.sharma@manchester.ac.uk.
A new interoperable solution enables pharmacogenomic-guided prescribing in England's primary care. This vendor-agnostic, standards-based approach integrates pharmacogenomic data and guidance into electronic health records (EHRs) at the point of care.
Area of Science:
- Health Informatics
- Clinical Pharmacology
- Genomics
Background:
- Pharmacogenomics offers personalized medicine by predicting drug response based on genetic makeup.
- Implementing pharmacogenomic-guided prescribing in routine clinical practice, particularly in primary care, presents significant technical and workflow challenges.
Purpose of the Study:
- To describe the implementation of an interoperable solution for pharmacogenomic-guided prescribing within the National Health Service (NHS) in England.
- To develop a system that integrates pharmacogenomic data and clinical guidance into primary care electronic health records (EHRs).
Main Methods:
- An iterative software development approach was employed, including clinical workflow mapping, system architecture design, development, and pilot testing.
- A commercial health data management platform was configured to store structured pharmacogenomic results.
- An open application programming interface (API) was developed for service deployment, enabling data exchange.
Main Results:
- The solution stores pharmacogenomic results and a knowledge base of guidance in a structured format.
- Deployed as a service via an open API, it allows third-party systems to query pharmacogenomic data using patient and medicine identifiers.
- The system was integrated with existing clinical decision support tools, delivering contextual information to prescribers within their EHRs.
Conclusions:
- An interoperable, vendor-agnostic, standards-based solution is crucial for implementing pharmacogenomic-guided prescribing across diverse care settings.
- Separating data from applications via APIs facilitates integration with various EHR systems, maximizing the utility of pharmacogenomic information at the point of prescribing.
More Related Videos
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Related Concept Videos
Biopharmaceutics and Pharmacokinetics: Overview
Analysis of Population Pharmacokinetic Data
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...